麻豆传媒

News — PHILADELPHIA, PA – August 13, 2024 – and Wexford Science & Technology, LLC, announced that Wistar has signed a lease for new laboratory and office space at uCity Square in Philadelphia to expand its capacity and resources essential for making groundbreaking discoveries that advance human health. Research teams from Wistar will move to 25,000 square feet of space on the 14th floor at 3675 Market Street later this month. The building is located within the dynamic uCity Square Knowledge Community being developed by Wexford and its partners the University City Science Center and Ventas, Inc. “Wistar is excited to expand its research and administrative presence into uCity Square by joining Philadelphia’s most diverse and dynamic community of university and commercial research activity,” said , president and CEO, director of the Ellen and Ronald Caplan Cancer Center and Robert and Penny Fox Distinguished Professor, at The Wistar Institute. “Establishing our new HIV Cure and Viral Diseases Center here allows us to attract the best talent, collaborate with new partners in industry and academia, and deliver the breakthrough new discoveries for which Wistar has been known for the last 130 years.”

The expansion marks an exciting new chapter in Wistar’s storied history as the nation’s first independent nonprofit institution devoted exclusively to foundational biomedical research and training. With this move, Wistar will have additional capacity for research on both its current campus and in uCity Square. This strategic expansion complements Wistar’s facilities at nearby 3601 Spruce Street, by providing its scientists with convenient, flexible, move-in ready lab spaces and direct access to state-of-the-art resources and shared facilities including CIC’s Innovation Labs, Charles River Laboratories CRADL facility, and the regular platform of programming offered by the Science Center, Wexford, and their other collaborators.

"We are thrilled that The Wistar Institute has chosen to expand to uCity Square, reinforcing our community as a premiere location to attract talent and accelerate innovation,” said Pete Cramer, Vice President and Market Executive at Wexford Science & Technology. “Wistar is a pioneering, forward-thinking, and accomplished institution within Philadelphia’s life sciences ecosystem and truly embodies our community’s culture of collaboration and innovation. We could not be more excited to support Wistar’s growth and look forward to its next generation of new discoveries."

This announcement further expands the collaboration between Wistar and uCity Square. Earlier this year, Wistar, along with PIDC, The Chamber of Commerce for Greater Philadelphia, and the West Philadelphia Skills Initiative, announced the first-ever, . It is currently underway with uCity Square tenant Integral Molecular and Navy Yard tenant Iovance Biotherapeutics. The 24-week paid training program begins with 10 weeks of evening classes at Wistar focused on preparing participants with a foundation in cellular and molecular biology as applicable to the life science industry. After the first 10 weeks, participants will take part in a full-time, hands-on laboratory orientation at Wistar before transitioning to externships at Integral Molecular at uCity Square or the Iovance iCTC (Cell Therapy Center) at the Navy Yard. Upon successful completion of the training program, applicants will have an opportunity to interview for open positions with Integral Molecular or Iovance Biotherapeutics with roles starting at $21/hour.

###

About The Wistar Institute

is the nation’s first independent nonprofit institution devoted exclusively to foundational biomedical research and training. Since 1972, the Institute has held National Cancer Institute (NCI)-designated Cancer Center status. Through a culture and commitment to biomedical collaboration and innovation, Wistar science leads to breakthrough early-stage discoveries and life science sector start-ups. Wistar scientists are dedicated to solving some of the world’s most challenging problems in the field of cancer and immunology, advancing human health through early-stage discovery and training the next generation of biomedical researchers. For more information, visit .

About uCity SquareLocated in Philadelphia’s University City neighborhood, uCity Square is an 8.0 million-square-foot mixed-use community consisting of laboratory, clinical, academic, office, retail, and residential space. As Philadelphia’s central hub for medical and life science innovations, particularly in cell and gene therapy, uCity Square is connected to top-tier colleges and universities, independent research institutions, world-renowned hospitals, and is a center of connectivity for residents, students, professionals, and entrepreneurs alike. uCity Square is a dynamic environment for innovation and collaboration among private industry and top-tier research institutions such as the University of Pennsylvania and its Hospital, Drexel University, Children’s Hospital of Philadelphia, Monell Chemical Senses Center, and The Wistar Institute. uCity Square is a development of Wexford Science & Technology, LLC, in partnership with the University City Science Center as the community’s primary engagement partner and Ventas, Inc. (NYSE: VTR) as the primary investor. For more information about uCity Square, visit .

About Wexford Science & Technology, LLC,
Wexford Science & Technology, LLC, is a real estate company exclusively focused on partnering with universities, academic medical centers, and research institutions to develop vibrant, mixed-use, amenity-rich Knowledge Communities that are built on a foundation of research, discovery, innovation, entrepreneurial activity, corporate engagement, and community inclusion. These Knowledge Communities create visible outcomes in the form of substantial economic growth, new and diverse jobs, and community transformation. Wexford targets strategic opportunities with top-tier research universities that are seeking to create knowledge-led economic development impact for their campuses, cities, and regions. Presently Wexford has developed or is developing seventeen Knowledge Communities across North America. For more information about Wexford, visit .

For media inquiries, please contact:Jen Tran for Wexford Science & Technology, 610-401-8421, [email protected]
Darien Sutton for The Wistar Institute, 215-870-2048, [email protected]